Anthony Polverino
2021 - Zymeworks
In 2021, Anthony Polverino earned a total compensation of $1.9M as Former Executive VP, Early Development & Chief Scientific Officer at Zymeworks, a 1% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,178,164 |
|---|---|
| Salary | $440,800 |
| Stock Awards | $282,913 |
| Other | $16,031 |
| Total | $1,917,908 |
Polverino received $1.2M in option awards, accounting for 61% of the total pay in 2021.
Polverino also received $440.8K in salary, $282.9K in stock awards and $16K in other compensation.
Rankings
In 2021, Anthony Polverino's compensation ranked 6,192nd out of 12,415 executives tracked by ExecPay. In other words, Polverino earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,192 out of 12,415 | 50th |
Division Manufacturing | 2,623 out of 5,501 | 52nd |
Major group Chemicals And Allied Products | 1,143 out of 2,371 | 52nd |
Industry group Drugs | 1,017 out of 2,092 | 51st |
Industry Pharmaceutical Preparations | 735 out of 1,542 | 52nd |
Source: SEC filing on November 25, 2022.
Polverino's colleagues
We found five more compensation records of executives who worked with Anthony Polverino at Zymeworks in 2021.